126 related articles for article (PubMed ID: 21623942)
21. The role of lymphadenectomy in high-grade invasive bladder cancer.
Stein JP; Skinner DG
Urol Clin North Am; 2005 May; 32(2):187-97. PubMed ID: 15862616
[TBL] [Abstract][Full Text] [Related]
22. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis.
Abdel-Latif M; Abol-Enein H; El-Baz M; Ghoneim MA
J Urol; 2004 Jul; 172(1):85-9. PubMed ID: 15201743
[TBL] [Abstract][Full Text] [Related]
23. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
Wright JL; Lin DW; Porter MP
Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
[TBL] [Abstract][Full Text] [Related]
24. Superiority of ratio based lymph node staging for bladder cancer.
Herr HW
J Urol; 2003 Mar; 169(3):943-5. PubMed ID: 12576818
[TBL] [Abstract][Full Text] [Related]
25. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
[TBL] [Abstract][Full Text] [Related]
27. The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer.
Quek ML; Sanderson KM; Daneshmand S; Stein JP
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1007-16. PubMed ID: 15606329
[TBL] [Abstract][Full Text] [Related]
28. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
Dhar NB; Klein EA; Reuther AM; Thalmann GN; Madersbacher S; Studer UE
J Urol; 2008 Mar; 179(3):873-8; discussion 878. PubMed ID: 18221953
[TBL] [Abstract][Full Text] [Related]
29. [A case of regionally metastatic pure squamous cell carcinoma of the urinary bladder successfully treated with radical chemoradiotherapy].
Inui M; Fujita K; Ueda N; Takenaka I; Kakehi Y
Hinyokika Kiyo; 2002 Jan; 48(1):33-5. PubMed ID: 11868383
[TBL] [Abstract][Full Text] [Related]
30. Extranodal extension in node-positive bladder cancer: the continuing controversy.
Jeong IG; Ro JY; Kim SC; You D; Song C; Hong JH; Ahn H; Kim CS
BJU Int; 2011 Jul; 108(1):38-43. PubMed ID: 21070576
[TBL] [Abstract][Full Text] [Related]
31. Surgical factors influence bladder cancer outcomes: a cooperative group report.
Herr HW; Faulkner JR; Grossman HB; Natale RB; deVere White R; Sarosdy MF; Crawford ED
J Clin Oncol; 2004 Jul; 22(14):2781-9. PubMed ID: 15199091
[TBL] [Abstract][Full Text] [Related]
32. Estimation of the true number of lymph nodes in lymphadenectomy specimens from radical cystectomy.
Jensen JB; Ulhøi BP; Jensen KM
Scand J Urol Nephrol; 2009; 43(4):288-92. PubMed ID: 19437191
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy specimens.
Resnick MJ; Bergey M; Magerfleisch L; Tomaszewski JE; Malkowicz SB; Guzzo TJ
BJU Int; 2011 Jan; 107(1):46-52. PubMed ID: 20880163
[TBL] [Abstract][Full Text] [Related]
34. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.
Konety BR; Joslyn SA; O'Donnell MA
J Urol; 2003 Mar; 169(3):946-50. PubMed ID: 12576819
[TBL] [Abstract][Full Text] [Related]
35. Stage specific lymph node metastasis mapping in radical cystectomy specimens.
Vazina A; Dugi D; Shariat SF; Evans J; Link R; Lerner SP
J Urol; 2004 May; 171(5):1830-4. PubMed ID: 15076287
[TBL] [Abstract][Full Text] [Related]
36. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
37. The role of pelvic lymph node dissection during radical cystectomy for bladder cancer.
Brunocilla E; Pernetti R; Martorana G
Anticancer Res; 2011 Jan; 31(1):271-5. PubMed ID: 21273609
[TBL] [Abstract][Full Text] [Related]
38. Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery.
Jensen JB; Ulhøi BP; Jensen KM
BJU Int; 2010 Jul; 106(2):199-205. PubMed ID: 20002670
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer.
Hugen CM; Polcari AJ; Fitzgerald MP; Dauw C; Flanigan RC; Quek ML
J Surg Oncol; 2010 Sep; 102(4):334-7. PubMed ID: 20607757
[TBL] [Abstract][Full Text] [Related]
40. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
